134 related articles for article (PubMed ID: 11856251)
1. In vitro activity, postantibiotic effect and human monocyte activity of grepafloxacin against Legionella species.
Dubois J; St-Pierre C
Clin Microbiol Infect; 1999 Apr; 5(4):205-212. PubMed ID: 11856251
[TBL] [Abstract][Full Text] [Related]
2. In vitro activity of gatifloxacin, compared with ciprofloxacin, clarithromycin, erythromycin, and rifampin, against Legionella species.
Dubois J; St-Pierre C
Diagn Microbiol Infect Dis; 1999 Apr; 33(4):261-5. PubMed ID: 10212753
[TBL] [Abstract][Full Text] [Related]
3. Comparative in vitro activity and post-antibiotic effect of gemifloxacin against Legionella spp.
Dubois J; St-Pierre C
J Antimicrob Chemother; 2000 Apr; 45 Suppl 1():41-6. PubMed ID: 10824031
[TBL] [Abstract][Full Text] [Related]
4. In vitro activity of sparfloxacin (CI-978; AT-4140) for clinical Legionella isolates, pharmacokinetics in guinea pigs, and use to treat guinea pigs with L. pneumophila pneumonia.
Edelstein PH; Edelstein MA; Weidenfeld J; Dorr MB
Antimicrob Agents Chemother; 1990 Nov; 34(11):2122-7. PubMed ID: 2073101
[TBL] [Abstract][Full Text] [Related]
5. In vitro activity of lomefloxacin (NY-198 or SC 47111), ciprofloxacin, and erythromycin against 100 clinical Legionella strains.
Edelstein PH; Gaudet EA; Edelstein MA
Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):93S-95S. PubMed ID: 2791505
[TBL] [Abstract][Full Text] [Related]
6. Antibacterial activities of gemifloxacin, levofloxacin, gatifloxacin, moxifloxacin and erythromycin against intracellular Legionella pneumophila and Legionella micdadei in human monocytes.
Baltch AL; Bopp LH; Smith RP; Michelsen PB; Ritz WJ
J Antimicrob Chemother; 2005 Jul; 56(1):104-9. PubMed ID: 15941776
[TBL] [Abstract][Full Text] [Related]
7. Effect of levofloxacin, erythromycin or rifampicin pretreatment on growth of Legionella pneumophila in human monocytes.
Smith RP; Baltch AL; Franke M; Hioe W; Ritz W; Michelsen P
J Antimicrob Chemother; 1997 Nov; 40(5):673-8. PubMed ID: 9421315
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity of various antibiotics against clinical strains of Legionella species isolated in Japan.
Miyashita N; Kobayashi I; Higa F; Aoki Y; Kikuchi T; Seki M; Tateda K; Maki N; Uchino K; Ogasawara K; Kurachi S; Ishikawa T; Ishimura Y; Kanesaka I; Kiyota H; Watanabe A
J Infect Chemother; 2018 May; 24(5):325-329. PubMed ID: 29459000
[TBL] [Abstract][Full Text] [Related]
9. In-vitro activity of RP 59500, a new synergic antibacterial agent, against Legionella spp.
Dubois J; Joly JR
J Antimicrob Chemother; 1992 Jul; 30 Suppl A():77-81. PubMed ID: 1399954
[TBL] [Abstract][Full Text] [Related]
10. In vitro activity of pazufloxacin, tosufloxacin and other quinolones against Legionella species.
Higa F; Akamine M; Haranaga S; Tohyama M; Shinzato T; Tateyama M; Koide M; Saito A; Fujita J
J Antimicrob Chemother; 2005 Dec; 56(6):1053-7. PubMed ID: 16260445
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of lomefloxacin (SC 47111 or NY-198) against isolates of Legionella spp.
Dubois J; Joly JR
Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):89S-91S. PubMed ID: 2791504
[TBL] [Abstract][Full Text] [Related]
12. WIN 57273 is bactericidal for Legionella pneumophila grown in alveolar macrophages.
Edelstein PH; Edelstein MA
Antimicrob Agents Chemother; 1989 Dec; 33(12):2132-6. PubMed ID: 2619277
[TBL] [Abstract][Full Text] [Related]
13. Comparative activity of ciprofloxacin, ofloxacin, levofloxacin, and erythromycin against Legionella species by broth microdilution and intracellular susceptibility testing in HL-60 cells.
Stout JE; Arnold B; Yu VL
Diagn Microbiol Infect Dis; 1998 Jan; 30(1):37-43. PubMed ID: 9488830
[TBL] [Abstract][Full Text] [Related]
14. Activity of azithromycin, clarithromycin, roxithromycin, dirithromycin, quinupristin/dalfopristin and erythromycin against Legionella species by intracellular susceptibility testing in HL-60 cells.
Stout JE; Arnold B; Yu VL
J Antimicrob Chemother; 1998 Feb; 41(2):289-91. PubMed ID: 9533475
[TBL] [Abstract][Full Text] [Related]
15. Comparative susceptibility of Legionella pneumophila and Legionella longbeachae to 12 antimicrobial agents.
Nimmo GR; Bull JZ
J Antimicrob Chemother; 1995 Jul; 36(1):219-23. PubMed ID: 8537269
[TBL] [Abstract][Full Text] [Related]
16. Activities of tigecycline and comparators against Legionella pneumophila and Legionella micdadei extracellularly and in human monocyte-derived macrophages.
Bopp LH; Baltch AL; Ritz WJ; Michelsen PB; Smith RP
Diagn Microbiol Infect Dis; 2011 Jan; 69(1):86-93. PubMed ID: 21146719
[TBL] [Abstract][Full Text] [Related]
17. In-vitro activity of six intracellular antibiotics against Legionella pneumophila strains of human and environmental origin.
Reda C; Quaresima T; Pastoris MC
J Antimicrob Chemother; 1994 Apr; 33(4):757-64. PubMed ID: 8056694
[TBL] [Abstract][Full Text] [Related]
18. Susceptibility testing by E-test and agar dilution of 30 strains of Legionella spp. isolated in Portugal.
Marques T; Piedade J
Clin Microbiol Infect; 1997 Jun; 3(3):365-368. PubMed ID: 11864134
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of macrolides against intracellular Legionella pneumophila.
Segreti J; Meyer P; Kapell K
Diagn Microbiol Infect Dis; 1996 Jul; 25(3):123-6. PubMed ID: 8902407
[TBL] [Abstract][Full Text] [Related]
20. Comparative activity of quinolones, macrolides and ketolides against Legionella species using in vitro broth dilution and intracellular susceptibility testing.
Stout JE; Sens K; Mietzner S; Obman A; Yu VL
Int J Antimicrob Agents; 2005 Apr; 25(4):302-7. PubMed ID: 15784309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]